Researchers evaluate the role of magnetic-resonance imaging in the clinical staging of prostate cancer in the definitive and salvage settings, and to identify changes in treatment recommendations.
Jonathan D. Tward, MD, PhD
Advertisement
Articles by Jonathan D. Tward, MD, PhD
Researchers evaluate the role of magnetic resonance imaging in the clinical staging of prostate cancer in the definitive and salvage settings, and to identify changes in treatment recommendations.
There are few controversies in oncology as divisive as the value of prostate-specific antigen (PSA) screening and subsequent treatment for prostate cancer.
Advertisement
Latest Updated Articles
Is Death From Prostate Cancer the Right Clinical Endpoint to Guide Screening and Treatment Choices?Published: July 3rd 2014 | Updated:
The Effect of Prostate MRI on Cancer Staging and Radiotherapy Treatment RecommendationsPublished: March 8th 2016 | Updated:
- The Effect of Prostate MRI on Cancer Staging and Radiotherapy Treatment Recommendations
Published: April 25th 2016 | Updated:
Advertisement
Advertisement
Trending on OncLive
1
FDA Approves Daratumumab and Hyaluronidase Plus VRd for Newly Diagnosed Multiple Myeloma
2
NP-G1-044 Receives FDA Orphan Drug Designation for Pancreatic Cancer
3
PD-L1 Expression Is More Predictive of Response to Pembrolizumab on Metastatic Sites in High-Grade Serous Ovarian Cancer
4
Meta-Analysis Characterizes Nivolumab/Ipilimumab Hyperprogression in Renal Medullary Carcinoma
5